Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Long intergenic non-protein coding RNA 2374 (LINC02374)** is a gene encoding a long intergenic non-coding RNA, part of the lincRNA class. LincRNAs are a subclass of long non-coding RNAs that are autonomously transcribed, do not overlap protein-coding genes, and are typically involved in fine-tuning gene expression, chromatin remodeling, and regulation of transcription[3][1]. The specific biological role and disease relevance of LINC02374 have not been functionally characterized in the literature as of yet. Unlike some better-studied lincRNAs (such as Xist or HOTAIR), LINC02374 lacks detailed mechanistic, functional, or clinical annotation.\n\nIn summary, **LINC02374** is a bona fide long intergenic non-coding RNA gene, but it is not a therapeutic target or clinically validated biomarker; no drugs, mechanisms of action, or prominent disease associations are yet established for this molecule[1][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2374 (LINC02374).